O'Byrne Jason
Insider CIK 1871145 · CRBU Chief Financial Officer · VIR EVP & Chief Financial Officer · OLMA CHIEF FINANCIAL OFFICER
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2026-09-01 | 2026-09-02 | 650,000 | — | $0 | 650,000 | SEC↗ |
| OLMA Olema Pharmaceuticals, Inc | A Award deriv | 2026-09-01 | 2026-09-02 | 650,000 | — | $0 | 650,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2026-03-20 | 2026-03-23 | 2,500 | — | $0 | 2,500 | SEC↗ |
| VIR Vir Biotechnology, Inc. | J Other | 2026-03-20 | 2026-03-23 | 2,500 | — | $0 | 160,115 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2026-02-24 | 2026-02-26 | 1,634 | $9.53 | $15.6K | 162,615 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2026-02-23 | 2026-02-24 | 2,089 | $7.45 | $15.6K | 164,249 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2026-02-22 | 2026-02-24 | 110,000 | — | $0 | 110,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2026-02-22 | 2026-02-24 | 55,000 | — | $0 | 166,338 | SEC↗ |
| VIR Vir Biotechnology, Inc. | S Sale | 2025-11-17 | 2025-11-18 | 6,799 | $5.56 | $37.8K | 110,701 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2025-02-22 | 2025-02-25 | 80,000 | — | $0 | 80,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2025-02-22 | 2025-02-25 | 40,000 | — | $0 | 115,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award deriv | 2024-11-15 | 2024-11-18 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VIR Vir Biotechnology, Inc. | A Award | 2024-11-15 | 2024-11-18 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2024-02-20 | 2024-02-22 | 153,000 | — | $0 | 153,000 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award | 2024-02-20 | 2024-02-22 | 33,000 | — | $0 | 59,224 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2023-02-21 | 2023-02-23 | 131,000 | — | $0 | 131,000 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | M Exercise deriv | 2022-02-08 | 2022-02-08 | 24,336 | — | $0 | 412,865 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | M Exercise | 2022-02-08 | 2022-02-08 | 24,336 | $4.11 | $100.0K | 24,336 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2021-12-20 | 2021-12-21 | 147,000 | — | $0 | 147,000 | SEC↗ |